Immune response by nasal delivery of hepatitis B surface antigen and codelivery of a CpG ODN in alginate coated chitosan nanoparticles
- 30 June 2008
- journal article
- Published by Elsevier BV in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 69 (2), 405-416
- https://doi.org/10.1016/j.ejpb.2008.01.019
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Induction of lymphocytes activated marker CD69 following exposure to chitosan and alginate biopolymersInternational Journal of Pharmaceutics, 2007
- Uptake of microparticles into the epithelium of human nasopharyngeal lymphoid tissueMedical Molecular Morphology, 2006
- Hepatitis vaccination among drug usersVaccine, 2006
- Progress in the control of hepatitis B infection in the Western Pacific RegionVaccine, 2006
- NALT- versus PEYER'S-patch-mediated mucosal immunityNature Reviews Immunology, 2004
- Mucosal immunogenicity of the hepatitis B core antigenBiochemical and Biophysical Research Communications, 2003
- CpG Motifs in Bacterial DNA and Their Immune EffectsAnnual Review of Immunology, 2002
- Carbohydrate Biopolymers Enhance Antibody Responses to Mucosally Delivered Vaccine AntigensInfection and Immunity, 2000
- CpG motifs in bacterial DNA trigger direct B-cell activationNature, 1995
- Ultrastructural study of M cells from colonic lymphoid nodules obtained by colonoscopic biopsyDigestive Diseases and Sciences, 1992